BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21681055)

  • 61. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study.
    Flick ED; Habel LA; Chan KA; Haque R; Quinn VP; Van Den Eeden SK; Sternfeld B; Orav EJ; Seeger JD; Quesenberry CP; Caan BJ
    Drugs; 2009 Jul; 69(11):1445-57. PubMed ID: 19634923
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.
    Singh S; Willig JH; Mugavero MJ; Crane PK; Harrington RD; Knopp RH; Kosel BW; Saag MS; Kitahata MM; Crane HM
    Clin Infect Dis; 2011 Feb; 52(3):387-95. PubMed ID: 21189273
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study.
    Waters L; Stebbing J; Mandalia S; Young AM; Nelson M; Gazzard B; Bower M
    Int J Cancer; 2005 Aug; 116(1):161-3. PubMed ID: 15756687
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of Statin Use With Kidney Damage and Function Among HIV-Infected Men.
    Ascher SB; Scherzer R; Nishtala A; Jotwani V; Grunfeld C; Parikh CR; Ng D; Wang R; Palella FJ; Shlipak MG; Estrella MM
    J Acquir Immune Defic Syndr; 2019 Oct; 82(2):202-210. PubMed ID: 31356467
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.
    Hernández-Ramírez RU; Qin L; Lin H; Leyden W; Neugebauer RS; Althoff KN; Achenbach CJ; Hessol NA; D'Souza G; Gebo KA; Gill MJ; Grover S; Horberg MA; Li J; Mathews WC; Mayor AM; Park LS; Rabkin CS; Salters K; Justice AC; Moore RD; Engels EA; Silverberg MJ; Dubrow R;
    Lancet HIV; 2019 Apr; 6(4):e240-e249. PubMed ID: 30826282
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
    Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
    Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biologic, clinical, and sociodemographic predictors of multi-agent systemic therapy for non-Hodgkin lymphoma in people living with HIV: a population-based investigation in the state of Georgia.
    Lipscomb J; Switchenko JM; Flowers CR; Gillespie TW; Wortley PM; Bayakly AR; Almon L; Fernando R; Ward KC
    Leuk Lymphoma; 2020 Apr; 61(4):896-904. PubMed ID: 31852329
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administration.
    Manfredi R; Calza L; Chiodo F
    J Biol Regul Homeost Agents; 2006; 20(1-2):1-9. PubMed ID: 18088548
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy.
    Dal Maso L; Rezza G; Zambon P; Tagliabue G; Crocetti E; Vercelli M; Zanetti R; Falcini F; Tonini G; Mangone L; De Lisi V; Ferretti S; Tumino R; Stanta G; Vitarelli S; Serraino D; Franceschi S;
    Int J Cancer; 2001 Aug; 93(3):430-5. PubMed ID: 11433410
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
    Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E;
    AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.
    Golomb BA; Kwon EK; Koperski S; Evans MA
    Drug Saf; 2009; 32(8):649-61. PubMed ID: 19591530
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
    Bhaskaran K; Brettle R; Porter K; Walker AS;
    AIDS; 2004 Mar; 18(4):673-81. PubMed ID: 15090773
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Statin use is associated with a decreased risk of Barrett's esophagus.
    Nguyen T; Khalaf N; Ramsey D; El-Serag HB
    Gastroenterology; 2014 Aug; 147(2):314-23. PubMed ID: 24798416
    [TBL] [Abstract][Full Text] [Related]  

  • 76. AIDS-related systemic non-Hodgkin's lymphoma at a large community program.
    Vilchez RA; Kozinetz CA; Jorgensen JL; Kroll MH; Butel JS
    AIDS Res Hum Retroviruses; 2002 Mar; 18(4):237-42. PubMed ID: 11860669
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
    Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
    Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Malignant lymphomas (ML) and HIV infection in Tanzania.
    Mwakigonja AR; Kaaya EE; Mgaya EM
    J Exp Clin Cancer Res; 2008 Jun; 27(1):9. PubMed ID: 18577266
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changing Patterns of Lymphoma in the Antiretroviral Therapy Era in Johannesburg, South Africa.
    Wiggill T; Mayne E; Perner Y; Vaughan J
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):252-260. PubMed ID: 34354010
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.
    Moore RD; Bartlett JG; Gallant JE
    PLoS One; 2011; 6(7):e21843. PubMed ID: 21765919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.